{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:31:21Z","timestamp":1791837081162,"version":"4.3.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00467-022-05846-1","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T16:21:53Z","timestamp":1675095713000},"page":"2623-2630","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Clinical and diagnostic utility of genomic sequencing for children referred to a Kidney Genomics Clinic with microscopic haematuria"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8719-5477","authenticated-orcid":false,"given":"Josiah","family":"Shanks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grainne","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kushani","family":"Jayasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Quinlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"key":"5846_CR1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/s0022-3476(79)80710-6","volume":"95","author":"VM Vehaskari","year":"1979","unstructured":"Vehaskari VM, Rapola J, Koskimies O, Savilahti E et al (1979) Microscopic hematuria in school children: epidemiology and clinicopathologic evaluation. J Pediatr 95:676\u2013684. https:\/\/doi.org\/10.1016\/s0022-3476(79)80710-6","journal-title":"J Pediatr"},{"key":"5846_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/s0022-3476(76)81012-8","volume":"88","author":"WF Dodge","year":"1976","unstructured":"Dodge WF, West EF, Smith EH, Harvey B 3rd (1976) Proteinuria and hematuria in schoolchildren: epidemiology and early natural history. J Pediatr 88:327\u2013347. https:\/\/doi.org\/10.1016\/s0022-3476(76)81012-8","journal-title":"J Pediatr"},{"key":"5846_CR3","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/jama.2011.1141","volume":"306","author":"A Vivante","year":"2011","unstructured":"Vivante A, Afek A, Frenkel-Nir Y, Tzur D et al (2011) Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease. JAMA 306:729\u2013736. https:\/\/doi.org\/10.1001\/jama.2011.1141","journal-title":"JAMA"},{"key":"5846_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1515\/dx-2015-0020","volume":"2","author":"M Clark","year":"2015","unstructured":"Clark M, Aronoff S, Del Vecchio M (2015) Etiologies of asymptomatic microscopic hematuria in children\u2014systematic review of 1092 subjects. Diagnosis (Berl) 2:211\u2013216. https:\/\/doi.org\/10.1515\/dx-2015-0020","journal-title":"Diagnosis (Berl)"},{"key":"5846_CR5","unstructured":"The Royal Children\u2019s Hospital, Melbourne, Australia (2021) Clinical practice guideline on haematuria. https:\/\/www.rch.org.au\/clinicalguide\/guideline_index\/Haematuria\/. Accessed 1 Sep 2022"},{"key":"5846_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00467-011-1939-1","volume":"27","author":"J Harambat","year":"2012","unstructured":"Harambat J, van Stralen KJ, Kim JJ, Tizard EJ (2012) Epidemiology of chronic kidney disease in children. Pediatr Nephrol 27:363\u2013373. https:\/\/doi.org\/10.1007\/s00467-011-1939-1","journal-title":"Pediatr Nephrol"},{"key":"5846_CR7","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/ki.2011.407","volume":"81","author":"O Gross","year":"2012","unstructured":"Gross O, Licht C, Anders HJ, Hoppe B et al (2012) Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int 81:494\u2013501. https:\/\/doi.org\/10.1038\/ki.2011.407","journal-title":"Kidney Int"},{"key":"5846_CR8","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.kint.2019.12.015","volume":"97","author":"O Gross","year":"2020","unstructured":"Gross O, T\u00f6nshoff B, Weber LT, Pape L et al (2020) A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport\u2019s syndrome. Kidney Int 97:1275\u20131286. https:\/\/doi.org\/10.1016\/j.kint.2019.12.015","journal-title":"Kidney Int"},{"key":"5846_CR9","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","volume":"361","author":"E W\u00fchl","year":"2009","unstructured":"ESCAPE Trial Group, W\u00fchl E, Trivelli A, Picca S et al (2009) Strict blood-pressure control and progression of renal failure in children. N Engl J Med 361:1639\u20131650. https:\/\/doi.org\/10.1056\/NEJMoa0902066","journal-title":"N Engl J Med"},{"key":"5846_CR10","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1016\/j.ekir.2021.08.028","volume":"6","author":"K Jayasinghe","year":"2021","unstructured":"Jayasinghe K, Wu Y, Stark Z, Kerr PG et al (2021) Cost-effectiveness of targeted exome analysis as a diagnostic test in glomerular diseases. Kidney Int Rep 6:2850\u20132861. https:\/\/doi.org\/10.1016\/j.ekir.2021.08.028","journal-title":"Kidney Int Rep"},{"key":"5846_CR11","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00467-020-04819-6","volume":"36","author":"CE Kashtan","year":"2021","unstructured":"Kashtan CE, Gross O (2021) Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults-an update for 2020. Pediatr Nephrol 36:711\u2013719. https:\/\/doi.org\/10.1007\/s00467-020-04819-6","journal-title":"Pediatr Nephrol"},{"key":"5846_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2215\/CJN.05890518","volume":"14","author":"CD Varnell Jr","year":"2019","unstructured":"Varnell CD Jr, Stone HK, Welge JA (2019) Bleeding complications after pediatric kidney biopsy: a systematic review and meta-analysis. Clin J Am Soc Nephrol 14:57\u201365. https:\/\/doi.org\/10.2215\/CJN.05890518","journal-title":"Clin J Am Soc Nephrol"},{"key":"5846_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"5846_CR14","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.2215\/CJN.01640309","volume":"4","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Work DF (2009) Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 4:1832\u20131843. https:\/\/doi.org\/10.2215\/CJN.01640309","journal-title":"Clin J Am Soc Nephrol"},{"key":"5846_CR15","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/s41588-019-0528-2","volume":"51","author":"AR Martin","year":"2019","unstructured":"Martin AR, Williams E, Foulger RE, Leigh S et al (2019) PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels. Nat Genet 51:1560\u20131565. https:\/\/doi.org\/10.1038\/s41588-019-0528-2","journal-title":"Nat Genet"},{"key":"5846_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/qjmed\/hcx030","volume":"110","author":"S Alkanderi","year":"2017","unstructured":"Alkanderi S, Yates LM, Johnson SA, Sayer JA (2017) Lessons learned from a multidisciplinary renal genetics clinic. QJM 110:453\u2013457. https:\/\/doi.org\/10.1093\/qjmed\/hcx030","journal-title":"QJM"},{"key":"5846_CR17","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.kint.2017.06.013","volume":"92","author":"AJ Mallett","year":"2017","unstructured":"Mallett AJ, McCarthy HJ, Ho G, Holman K et al (2017) Massively parallel sequencing and targeted exomes in familial kidney disease can diagnose underlying genetic disorders. Kidney Int 92:1493\u20131506. https:\/\/doi.org\/10.1016\/j.kint.2017.06.013","journal-title":"Kidney Int"},{"key":"5846_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/jgc4.1560","author":"A Levin Fridman","year":"2022","unstructured":"Levin Fridman A, Raz A, Timmermans S, Shkedi-Rafid S (2022) Views of Israeli healthcare professionals regarding communication of genetic variants of uncertain significance to patients. J Genet Couns. https:\/\/doi.org\/10.1002\/jgc4.1560","journal-title":"J Genet Couns"},{"key":"5846_CR19","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1056\/NEJMra022296","volume":"348","author":"BG Hudson","year":"2003","unstructured":"Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG (2003) Alport\u2019s syndrome, Goodpasture\u2019s syndrome, and type IV collagen. N Engl J Med 348:2543\u20132556. https:\/\/doi.org\/10.1056\/NEJMra022296","journal-title":"N Engl J Med"},{"key":"5846_CR20","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.2215\/CJN.00580116","volume":"11","author":"J Savige","year":"2016","unstructured":"Savige J, Colville D, Rheault M, Gear S, Lennon R, Lagas S, Finlay M, Flinter F (2016) Alport syndrome in women and girls. Clin J Am Soc Nephrol 11:1713\u20131720. https:\/\/doi.org\/10.2215\/CJN.00580116","journal-title":"Clin J Am Soc Nephrol"},{"key":"5846_CR21","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1097\/01.asn.0000090034.71205.74","volume":"14","author":"JP Jais","year":"2003","unstructured":"Jais JP, Knebelmann B, Giatras I, De Marchi M et al (2003) X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a \u201cEuropean Community Alport Syndrome Concerted Action\u201d study. J Am Soc Nephrol 14:2603\u20132610. https:\/\/doi.org\/10.1097\/01.asn.0000090034.71205.74","journal-title":"J Am Soc Nephrol"},{"key":"5846_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-022-05627-w","author":"JL Alge","year":"2022","unstructured":"Alge JL, Bekheirnia N, Willcockson AR, Qin X et al (2022) Variants in genes coding for collagen type IV \u03b1-chains are frequent causes of persistent, isolated hematuria during childhood. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-022-05627-w","journal-title":"Pediatr Nephrol"},{"key":"5846_CR23","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1038\/s41598-022-06525-9","volume":"12","author":"JT Gibson","year":"2022","unstructured":"Gibson JT, Huang M, Shenelli Croos Dabrera M, Shukla K et al (2022) Genotype-phenotype correlations for COL4A3-COL4A5 variants resulting in Gly substitutions in Alport syndrome. Sci Rep 12:2722. https:\/\/doi.org\/10.1038\/s41598-022-06525-9","journal-title":"Sci Rep"},{"key":"5846_CR24","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.kint.2020.06.038","volume":"98","author":"T Yamamura","year":"2020","unstructured":"Yamamura T, Horinouchi T, Nagano C, Omori T et al (2020) Genotype-phenotype correlations influence the response to angiotensin-targeting drugs in Japanese patients with male X-linked Alport syndrome. Kidney Int 98:1605\u20131614. https:\/\/doi.org\/10.1016\/j.kint.2020.06.038","journal-title":"Kidney Int"},{"key":"5846_CR25","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1681\/ASN.2009070784","volume":"21","author":"MR Bekheirnia","year":"2010","unstructured":"Bekheirnia MR, Reed B, Gregory MC, McFann K et al (2010) Genotype-phenotype correlation in X-linked Alport syndrome. J Am Soc Nephrol 21:876\u2013883. https:\/\/doi.org\/10.1681\/ASN.2009070784","journal-title":"J Am Soc Nephrol"},{"key":"5846_CR26","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ekir.2017.04.011","volume":"2","author":"T Yamamura","year":"2017","unstructured":"Yamamura T, Nozu K, Fu XJ, Nozu Y et al (2017) Natural history and genotype-phenotype correlation in female X-linked Alport syndrome. Kidney Int Rep 2:850\u2013855. https:\/\/doi.org\/10.1016\/j.ekir.2017.04.011","journal-title":"Kidney Int Rep"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05846-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-022-05846-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05846-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T07:12:32Z","timestamp":1690873952000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-022-05846-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["5846"],"URL":"https:\/\/doi.org\/10.1007\/s00467-022-05846-1","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,30]]},"assertion":[{"value":"4 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research study was conducted retrospectively from data obtained for clinical purposes. We consulted extensively with the Royal Children\u2019s Hospital research office who determined that our study could proceed with ethics approval via the low or negligible risk pathway. The study was conducted in accordance with the NHMRC Ethical Considerations in Quality Assurance and Evaluation Activities (2014) guideline.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}